Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Paclitaxel × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 35 Breast Neoplasms 24 Lung Neoplasms 15 Ovarian Neoplasms 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Endometrial Neoplasms 11 Triple Negative Breast Neoplasms 10 Fallopian Tube Neoplasms 10 Neoplasm Metastasis 8 Squamous Cell Carcinoma of Head and Neck 7 Neoplasms 7 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Colorectal Neoplasms 6 Carcinoma 6 Stomach Neoplasms 5 Uterine Cervical Neoplasms 4 Small Cell Lung Carcinoma 4 Head and Neck Neoplasms 4 Adenocarcinoma Of Esophagus 4 Urinary Bladder Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Uterine Neoplasms 2 Rectal Neoplasms 2 Pathologic Complete Response 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2

Interventions

Cyclophosphamide 10 fludarabine 8 Rituximab 8 Dexamethasone 8 pembrolizumab 7 venetoclax 5 glofitamab 5 Lenalidomide 5 obinutuzumab 4 Etoposide 4 Calcium Dobesilate 4 pomalidomide 3 Temozolomide 3 Doxorubicin 3 Cytarabine 3 zanubrutinib 2 tocilizumab 2 tisagenlecleucel 2 selinexor 2 ruxolitinib 2 ibrutinib 2 enzalutamide 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 carfilzomib 2 abemaciclib 2 Vincristine 2 Surgical Procedures, Operative 2 Radiotherapy 2 Prednisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡